Education
About Us
Working with TipRanks
Follow Us
Azitra Inc (AZTR)
:AZTR
AZTR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.69 - $4.32
Previous CloseN/A
Volume201.32K
Average Volume (3M)5.37M
Market Cap
$3.78M
Enterprise Value$3.79M
Total Cash (Recent Filing)$1.05B
Total Debt (Recent Filing)$577.86M
Price to Earnings (P/E)―
Beta1.45
Next Earnings
Nov 18, 2025EPS Estimate
-0.76Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.20
Shares Outstanding5,404,968
10 Day Avg. Volume152,793
30 Day Avg. Volume5,373,574
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit0.51
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$0.50Price Target Upside-28.57% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Clinical TrialsFocus remains on lead program ATR-12 in Netherton syndrome, which dosed the first patient in its P1b study, with initial data expected soon.
Regulatory ApprovalsATR-04 has fast track designation, indicating a streamlined development process to potentially bring the therapy to market sooner.
Bears Say
Financial PerformanceFactoring in dilution associated with the two recent financings lowers the 12-month price target to $2.00, from $3.00.
Azitra Inc News
AZTR FAQ
What was Azitra Inc’s price range in the past 12 months?
Azitra Inc lowest stock price was $0.69 and its highest was $4.32 in the past 12 months.
What is Azitra Inc’s market cap?
Azitra Inc’s market cap is $3.78M.
When is Azitra Inc’s upcoming earnings report date?
Azitra Inc’s upcoming earnings report date is Nov 18, 2025 which is in 49 days.
How were Azitra Inc’s earnings last quarter?
Azitra Inc released its earnings results on Aug 11, 2025. The company reported -$1.199 earnings per share for the quarter, beating the consensus estimate of -$1.399 by $0.2.
Is Azitra Inc overvalued?
According to Wall Street analysts Azitra Inc’s price is currently Overvalued.
Does Azitra Inc pay dividends?
Azitra Inc does not currently pay dividends.
What is Azitra Inc’s EPS estimate?
Azitra Inc’s EPS estimate is -0.76.
How many shares outstanding does Azitra Inc have?
Azitra Inc has 5,404,968 shares outstanding.
What happened to Azitra Inc’s price movement after its last earnings report?
Azitra Inc reported an EPS of -$1.199 in its last earnings report, beating expectations of -$1.399. Following the earnings report the stock price went down -7.547%.
Which hedge fund is a major shareholder of Azitra Inc?
Currently, no hedge funds are holding shares in AZTR
Company Description
Azitra Inc
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
AZTR Stock 12 Month Forecast
Average Price Target
$0.50
▼(-28.57% Downside)
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Protagenic Therapeutics
―
Ownership Overview
5.80% Insiders
2.02% Mutual Funds
0.29% Other Institutional Investors
97.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---